People enrolled in early stage trials for possible cancer treatments may underestimate the risks involved and overestimate the potential benefits, suggests a new study.
- About
- Projects
- Library
- Bibliography of Bioethics
- Bioethics News
- For Students
- Contacts
- NBNPM
- Advanced Certificate Program
Papildomos nuorodos
